USH2A and retinitis pigmentosa 1: In this current study, we established patient-specific iPSC cell lines with USH2A mutations (c.8559–2A>G and c.9127_9129delTCC) (KLRMMEi001-A), followed by ROs and RPE differentiation from the iPSCs to create an in vitro RP disease model.